BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36787514)

  • 1. Cascade-Responsive 2-DG Nanocapsules Encapsulate aV-siCPT1C Conjugates to Inhibit Glioblastoma through Multiple Inhibition of Energy Metabolism.
    Zhang Y; Ren Y; Xu H; Li L; Qian F; Wang L; Quan A; Ma H; Liu H; Yu R
    ACS Appl Mater Interfaces; 2023 Mar; 15(8):10356-10370. PubMed ID: 36787514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy.
    Zhang Y; Ma H; Li L; Sun C; Yu C; Wang L; Xu D; Song X; Yu R
    Adv Mater; 2024 Apr; ():e2400502. PubMed ID: 38651254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
    Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
    Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
    Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
    Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
    Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
    J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy.
    Zhou Y; Guo Y; Chen L; Zhang X; Wu W; Yang Z; Li X; Wang Y; Hu Z; Wang Z
    Theranostics; 2022; 12(12):5488-5503. PubMed ID: 35910792
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
    Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
    Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma.
    Hsieh HT; Huang HC; Chung CW; Chiang CC; Hsia T; Wu HF; Huang RL; Chiang CS; Wang J; Lu TT; Chen Y
    J Control Release; 2022 Dec; 352():920-930. PubMed ID: 36334859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
    Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
    Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
    Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
    ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis.
    Wang W; Zhang M; Zhang Q; Mohammadniaei M; Shen J; Sun Y
    J Control Release; 2022 Dec; 352():399-410. PubMed ID: 36309097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2.
    Yang C; Wu Y; Wang L; Li S; Zhou J; Tan Y; Song J; Xing H; Yi K; Zhan Q; Zhao J; Wang Q; Yuan X; Kang C
    J Control Release; 2022 May; 345():537-548. PubMed ID: 35341902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma.
    Cesarini V; Scopa C; Silvestris DA; Scafidi A; Petrera V; Del Baldo G; Gallo A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.
    Fraga Dias A; Dallemole DR; Bruinsmann FA; Lopes Silva LF; Cruz-López O; Conejo-García A; Oliveira Battastini AM; Campos JM; Guterres SS; Pohlmann AR; Figueiró F
    Nanomedicine (Lond); 2021 Oct; 16(23):2095-2115. PubMed ID: 34523353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.